Violation Tracker Individual Record
Company:U.S. Bioservices Corporation
Date:September 7, 2017
Offense Group:competition-related offenses
Primary Offense:kickbacks and bribery
U.S. Bioservices agreed to pay $13.4 million to settle multistate allegations that it recommended the drug Exjade to Medicaid patients in exchange for kickbacks from Novartis Pharmaceuticals Corporation, which marketed the drug.
Level of Government:state
Action Type:agency action
Agency:Multistate Attorneys General Case
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:Pennsylvania
Ownership Structure of Parent:publicly traded
Major Industry of Parent:wholesalers
Specific Industry of Parent:wholesalers-pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.